Description
Retatrutide is a synthetic peptide that acts as a triple agonist of the GIP, GLP-1, and glucagon receptors. Each vial contains 10mg of lyophilized retatrutide supplied for in vitro laboratory research.
Compound Overview
Retatrutide combines agonist activity at three receptors in a single molecule: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon. It is used as a reference compound in comparative studies of single-, dual-, and triple-receptor incretin pharmacology. Like other long-acting incretin analogues, its structure includes a fatty-acid modification that promotes albumin binding.
Areas of Research Interest
- Triple-receptor (GIP / GLP-1 / glucagon) signaling pharmacology
- Receptor binding and selectivity comparisons with single and dual agonists
- Glucagon receptor signaling in metabolic research models
- Peptide stability and half-life extension studies
Product Specifications
- Contents: 10mg retatrutide per vial
- Form: Lyophilized (freeze-dried) powder
- Storage: Store at -20°C, protected from light. Minimize freeze-thaw cycles after reconstitution.
Research Use Only
This product is sold strictly for laboratory research use only. It is not a drug, food, dietary supplement, or cosmetic, and it is not intended for human or animal consumption, injection, or any diagnostic or therapeutic use. It has not been approved by the FDA to diagnose, treat, cure, or prevent any disease or condition. Purchase is limited to qualified researchers aged 21 and older. By purchasing, the buyer agrees to handle this product in accordance with all applicable laws and laboratory safety practices.




Reviews
There are no reviews yet.